These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Molecular pathogenesis of meningiomas. Perry A; Gutmann DH; Reifenberger G J Neurooncol; 2004 Nov; 70(2):183-202. PubMed ID: 15674477 [TBL] [Abstract][Full Text] [Related]
3. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Lusis EA; Watson MA; Chicoine MR; Lyman M; Roerig P; Reifenberger G; Gutmann DH; Perry A Cancer Res; 2005 Aug; 65(16):7121-6. PubMed ID: 16103061 [TBL] [Abstract][Full Text] [Related]
4. Masked hypodiploidy in anaplastic meningiomas by duplication of the original clone found in atypical meningiomas: illustration of the evolution of genetic alterations. Ely EE; Guzman MA; Calvey LS; Batanian JR Neuropathology; 2014 Aug; 34(4):353-9. PubMed ID: 24612240 [TBL] [Abstract][Full Text] [Related]
5. Anaplastic meningioma: progression from atypical and chordoid morphotype with morphologic spectral variation at recurrence. Bollag RJ; Vender JR; Sharma S Neuropathology; 2010 Jun; 30(3):279-87. PubMed ID: 19780983 [TBL] [Abstract][Full Text] [Related]
6. Genetic alterations associated with progression and recurrence in meningiomas. Pérez-Magán E; Campos-Martín Y; Mur P; Fiaño C; Ribalta T; García JF; Rey JA; Rodríguez de Lope A; Mollejo M; Meléndez B J Neuropathol Exp Neurol; 2012 Oct; 71(10):882-93. PubMed ID: 22964784 [TBL] [Abstract][Full Text] [Related]
7. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions? Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670 [TBL] [Abstract][Full Text] [Related]
8. KLF4 is a tumor suppressor in anaplastic meningioma stem-like cells and human meningiomas. Tang H; Zhu H; Wang X; Hua L; Li J; Xie Q; Chen X; Zhang T; Gong Y J Mol Cell Biol; 2017 Aug; 9(4):315-324. PubMed ID: 28651379 [TBL] [Abstract][Full Text] [Related]
9. Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas. Combs SE; Schulz-Ertner D; Debus J; von Deimling A; Hartmann C Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1415-21. PubMed ID: 20932661 [TBL] [Abstract][Full Text] [Related]
10. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas. Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900 [TBL] [Abstract][Full Text] [Related]
11. ARID1A and TERT promoter mutations in dedifferentiated meningioma. Abedalthagafi MS; Bi WL; Merrill PH; Gibson WJ; Rose MF; Du Z; Francis JM; Du R; Dunn IF; Ligon AH; Beroukhim R; Santagata S Cancer Genet; 2015 Jun; 208(6):345-50. PubMed ID: 25963524 [TBL] [Abstract][Full Text] [Related]
12. Histological classification and molecular genetics of meningiomas. Riemenschneider MJ; Perry A; Reifenberger G Lancet Neurol; 2006 Dec; 5(12):1045-54. PubMed ID: 17110285 [TBL] [Abstract][Full Text] [Related]
13. Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization. Ishino S; Hashimoto N; Fushiki S; Date K; Mori T; Fujimoto M; Nakagawa Y; Ueda S; Abe T; Inazawa J Cancer; 1998 Jul; 83(2):360-6. PubMed ID: 9669820 [TBL] [Abstract][Full Text] [Related]
14. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924 [TBL] [Abstract][Full Text] [Related]
15. PS6K amplification characterizes a small subset of anaplastic meningiomas. Cai DX; James CD; Scheithauer BW; Couch FJ; Perry A Am J Clin Pathol; 2001 Feb; 115(2):213-8. PubMed ID: 11211609 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment. Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521 [TBL] [Abstract][Full Text] [Related]
17. The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments. Choy W; Kim W; Nagasawa D; Stramotas S; Yew A; Gopen Q; Parsa AT; Yang I Neurosurg Focus; 2011 May; 30(5):E6. PubMed ID: 21529177 [TBL] [Abstract][Full Text] [Related]